Skip to content

Visualmed

Clinical trials summarized as Visual Abstracts

Menu
  • Home

TRED HF Trial: Withdrawal of treatment for HF with recovered dilated cardiomyopathy

by adminPosted onMay 2, 2020July 24, 2020
Posted in Cardiovascular Disease, NephrologyTagged ACEi, cardiomyopathy, heart failure, neurohormonal blockade

Post navigation

Prev TREAT Trial: Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Next TRICC Trial: Transfusion Requirements in Critical Care




Download the App

Recent Posts

  • Tocilizumab in hospitalized patients with COVID-19
  • VERTIS CV Trial: Ertugliflozin Effect on CV Outcomes in Type 2 Diabetes
  • EMPEROR Reduced Trial: Empagliflozin in HFrEF
  • REALITY Trial: Transfusion in Patients With Myocardial Infarction and Anemia
  • EAST AFNET 4 Trial: Early Rhythm control in Afib
Amphibious Theme by TemplatePocket ⋅ Powered by WordPress